MaxCyte
MXCT
MXCT
104 hedge funds and large institutions have $376M invested in MaxCyte in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 108 → 104 (-4)
17% less capital invested
Capital invested by funds: $452M → $376M (-$76.4M)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
104
Holding in Top 10
5
Calls
$19K
Puts
$21K
Top Buyers
| 1 | +$5.28M | |
| 2 | +$3.16M | |
| 3 | +$2.59M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.11M |
| 5 |
BlackRock
New York
|
+$2M |
Top Sellers
| 1 | -$6.72M | |
| 2 | -$3.14M | |
| 3 | -$2.68M | |
| 4 |
Goldman Sachs
New York
|
-$1.83M |
| 5 |
Holocene Advisors
New York
|
-$1.66M |